Brief: Cognition Therapeutics Reports Year End 2022 Financial Results And Provides Business Update
23/03/2023 11:37
March 23 (Reuters) - Cognition Therapeutics Inc
CGTX.O :
* COGNITION THERAPEUTICS REPORTS YEAR END 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* COGNITION THERAPEUTICS INC FY LOSS PER SHARE $0.91
* COGNITION THERAPEUTICS INC - SECURED EQUITY COMMITMENT OF
UP TO
AN ADDITIONAL $35M ENABLING POTENTIAL ACCESS TO CAPITAL
* COGNITION THERAPEUTICS - ESTIMATES IT HAS SUFFICIENT CASH
TO
FUND OPERATIONS AND CAPITAL EXPENDITURES INTO SECOND HALF OF
2024
Source text for Eikon: ID:nGNX4tF2Fq
Further company coverage: CGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cognition Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Cognition rises after FDA backs late-stage trial plan for dementia drug
Brief: Cognition Therapeutics Announces Issuance Of Composition Of Matter Patent, Extending Protection For Zervimesine (CT1812) Through 2045
Brief: Cognition Therapeutics Schedules A Type C Meeting With FDA To Align On Endpoints For Phase 3 Trial Of Zervimesine (Ct1812) In DLB